OBJECTIVES--To compare the length of survival and quality of life in patients given combination
chemotherapy in addition to supportive care and in patients given only supportive care. …

… Kornek, Roche; Werner Scheithauer, Roche Research Funds: Bengt Glimelius, Funds,
Merck, Sanofi-Aventis; Emilio Bajetta, Funds, Roche SpA; Arie Figer, Funds, Roche, Swiss …

Cancer patients are at high risk for venous thromboembolism (VTE). Laboratory parameters
with a predictive value for VTE could help stratify patients into high- or low-risk groups. The …

Objective Patients with cancer may display elevated levels of B-type natriuretic peptide (BNP)
and high-sensitive troponin T (hsTnT) without clinical manifestation of cardiac disease. …

Background. Few data are available on the safety and efficacy of sorafenib in patients with
multifocal hepatocellular carcinoma (HCC) and advanced liver cirrhosis. Methods. Between …

Purpose: We assessed the influence of hemoglobin level and r-HuEPO administration on
response to chemoradiotherapy, locoregional tumor control, and overall survival in patients …

Iron deficiency and iron deficiency-associated anemia are common complications in cancer
patients. Most iron deficient cancer patients present with functional iron deficiency (FID), a …

Purpose: In order to determine whether infection with Helicobacter pylori might be
associated with pancreatic adenocarcinoma, we performed a study to compare the H. pylori …

The constantly growing list of cytotoxic chemotherapeutics requires a new survey of ophthalmic
complications, which are often underestimated. Based on the review by Imperia et al (…

Purpose: Capecitabine and oxaliplatin, two new agents with potential synergistic activity,
have demonstrated promising antitumor efficacy in advanced colorectal cancer (ACC). …